[15860] in Public-Access_Computer_Systems_Forum
Do you have a Portfolio
daemon@ATHENA.MIT.EDU (michale franzen)
Tue Jun 14 23:49:30 2005
Message-ID: <001801c5715d$36bfe4d0$228c35c9@IFYZWK>
From: "michale franzen" <barbfaulk@acsinc.net>
To: <ppisani@mit.edu>, <kosuke@mit.edu>, <sduty@mit.edu>, <lemay@mit.edu>,
<chu@mit.edu>, <pacs@mit.edu>, <josephd@mit.edu>, <jeffd@mit.edu>,
<ngoodman@mit.edu>, <teehee@mit.edu>, <tgarner@mit.edu>
Date: Tue, 14 Jun 2005 20:49:21 -0800
MIME-Version: 1.0
Content-Type: multipart/alternative;
boundary="----=_NextPart_000_0015_01C57122.8A610CD0"
This is a multi-part message in MIME format.
------=_NextPart_000_0015_01C57122.8A610CD0
Content-Type: text/plain;
charset="iso-8859-1"
Content-Transfer-Encoding: 7Bit
Big news expected This should invoke large gains
PGCN has gained over $1.00 since Monday the 13th.
This stock will explode the end of this week.
Do not wait until it is too late.
New news expected this week. Expected 7 day price $9.00
(SYMBOL: PGCN)
Price: $1.88 (up from $.50 Last 4 days of trading)
Short Term Target: $27-$35
12month Target: $50.00
************************************************
Tuesday June 14, 10:00 am ET
BIG NEWS TODAY
HARBIN, China, June 14 Xinhua PRNewswire FirstCall
Pingchuan Pharmaceutical Inc. (OTC Bulletin Board: PGCN - News; ''PGCN'')
announced today that PGCN signed a Regional Distribution Contract with Beijing
Pingchuan Tianzhi Medical Technology Development Center (''TIANZHI''), a subsidiary
wholly invested by Pingchuan Pharmaceutical Inc
*************************************************
Pingchuan Summary:
Harbin Pingchuan Pharmaceutical Holding Co., Ltd. ("PINGCHUAN") (PGCN) was
established in March 2001 in Harbin city, P.R.China. It is a modernized
pharmaceutical manufacturer with first-class medical R&D ability, pioneered
medicine products, and well-established marketing network.
Harbin Pingchuan Traditional Chinese Medicine Research Institute was
established in June 1998, with a registered capital of US $120,000. Currently
it has 60 employees, 20 of them are professionals and experts on diabetes.
Functioning as the R&D base of PINGCHUAN, the institute focuses on R & D of
new medicines, particularly those on diabetes.
Since the establishment of 2001, PINGCHUAN has developed a series of
diabetes medicine, including antibiotics, chemical medical capsules and
traditional Chinese medicine. Kang Da Glycosuria Capsule is one of the
successful products of PINGCHUAN for treating diabetes. It was first
developed in 1998 and introduced to the market in 2001. PINGCHUAN also
produces medical intermediates and pharmaceutical preparations, medical
instruments, health care food and other related products.
PINGCHUAN has well-established marketing network and sale branches,
including about 180,000 retail pharmacies/drugstores across China, agency
network in major cities like Beijing, Shanghai, Guangzhou, and Xi'an,
special sales counter at drug chain stores in key regions, residence
community clinic sale and promotion, as well as internet marketing through
the company's website. The marketing network of PINGCHUAN covers more than
50% districts of China and exports to US, Japan, Russia, and south-eastern
Asia.
Example:
CWTD in February 2004 at 90 cents before it went to $8.50, an increase of
800 PERCENT !! In March MAMA at 3.95 shortly before hitting a high of $13.30
over 400 PERCENT !!! But We expect much more from PGCN, Sit back and watch.
presidencypendingthe election The opposition
------=_NextPart_000_0015_01C57122.8A610CD0--
